Physician profile
Nimaljeet K Tarango
NPI 1205841970
$2,831.66
in general payments reported to CMS, 2019-2025
6 companies · $1,552 in 2025
The $1,552 reported for 2025 was more than what 96% of Medical-Surgical (Registered Nurse) providers received nationally (typical 2025 total: $93.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $278 · 2023: $409 · 2024: $592 · 2025: $1,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890 · Travel and Lodging: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,889.83 |
| Travel and Lodging | $663.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,159.14 | 2025 | Barostim Neo System |
| Abbott Laboratories | $1,052.91 | 2022-2025 | 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $241.66 | 2024 | Impella |
| Nuwellis, INC. | $214.92 | 2023-2024 | Aquadex Smartflow Console |
| E.R. Squibb & Sons, L.L.C. | $122.18 | 2022 | |
| Paragonix Technologies, INC. | $40.85 | 2023 | Paragonix Sherpapak Cardiac Transport System, Cts Canister Box, Sherpacool Box |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nimaljeet Tarango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.